Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

Search Filters
HigherLogic Feed ID
5347a8c8-cae8-4f82-b108-c12f5ffbf010
Docebo ID
14
NetForum Committee Code
20
Elevate ID
12542

Healthcare supply chains are facing unprecedented challenges from regulatory shifts, supply shortages, global health emergencies, and new tariff proposals from the Trump administration. For in-house counsel and supply chain professionals within healthcare organizations, mitigating risk and ensuring contract and supply chain resilience is essential to safeguarding patient care and maintaining operational continuity. In this practical session, led by Vanessa Miller and Greg Husisian, participants will learn actionable strategies for drafting and negotiating contracts that secure continuous access to vital medical supplies, uphold stringent regulatory standards, foster robust supplier partnerships, and help ensure that their companies understand the supply chain risks arising out of the new Trump tariffs and other international trade priorities of the new administration. Attendees will gain key insights into structuring contracts for agility during crises, managing pricing volatility in pharmaceuticals and medical devices, and effectively resolving disputes to protect both patient outcomes and organizational stability.

Key Takeaways:

  • Crafting specialized force majeure and contingency clauses that address healthcare-specific disruptions—including pandemics, regulatory changes, new tariffs, and supplier shortages.
  • Effectively managing tariffs and pricing volatility in pharmaceuticals and medical devices, while incorporating risk-sharing mechanisms tailored to healthcare needs.
  • Implementing best practices in contract negotiation to ensure supply continuity, maintain regulatory compliance, and cultivate long-term supplier partnerships.
  • Developing escalation strategies and leveraging contractual provisions to swiftly resolve supply chain disputes and minimize impacts on patient care.


Join the Conversation:

 Health Law Network Community

Sponsored by: 

image

On January 7 at 12pm ET, join us for 3 rounds of speed networking. Members will be broken up into groups of 4-5 to discuss "fun" topics for approximately 15 minutes. We will share our favorite books, pastimes, most entertaining shows, documentaries, movies, and grow our connections with our in-house peers. Speed networking is a great way to quickly expand your network and meet colleagues that are facing similar challenges in their daily work! Don't miss this chance to meet 16 new people (if you're lucky) in only one hour. You might even just win a gift card!

Join the Conversation:

 Health Law Network Community

Sponsored by: 

image

Explore healthcare fraud litigation and investigations from the perspective of legal enforcers. This panel of healthcare law enforcers will share what enforcers focus on and what it means for in-house counsel. Gain valuable perspectives on government priorities and trends and discover the inner workings of an investigation from the government’s point of view. Stay up to date on civil, criminal, and administrative updates and get practical advice directly from the enforcers themselves.

Lori Garber, Partner (Foley & Lardner LLP)

This article provides an overview of the False Claims Act (FCA).

In this article you will learn about, the types of FCA cases in health care, damages and penalties under the FCA, and cooperation considerations for companies and individuals under government scrutiny.

This program will cover key considerations when using telemedicine in clinical trials so in-house counsel can issue spot and advise their clients on this important and burgeoning clinical trial modality.

image

This program will cover key considerations when using telemedicine in clinical trials so in-house counsel can issue spot and advise their clients on this important and burgeoning clinical trial modality.

image

This Webcast will provide a general overview of the November 2023 release of the Office of Inspector General's (OIG) General Compliance Program Guidance (GCPG) including key risk areas, discuss the most notable updates, changes and emphasis by the OIG since the original release of Compliance Program Guidance in the Federal Register, and provide a summary of recent enforcement actions for consideration by compliance officers when developing their 2024 compliance work plan.

image
Foley & Lardner LLP
28 pages

Foley & Lardner’s Top Trends for 2024 publication unpacks key developments in an uncertain regulatory landscape.

Roger D. Strode, Mark C. Grundvig, Kate L. Pamperin, Joseph T. Simon, and Benjamin R. Dryden (Foley & Lardner LLP)
8 pages

On April 23, 2024, the U.S. Federal Trade Commission finalized a rule, by a vote of 3-2, abolishing the vast majority of employee covenants not to compete across the United States.

While certain health care providers will be exempted from the rule, many will not. As such, and if the rule survives legal challenge, health care industry participants should carefully consider how the rule will impact their recruitment and retention strategies going forward.

Resource Details
Region: United States
Subscribe to Health Law Network